Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
04/08/1986 | CA1202892A1 Tumor imaging with radiolabeled monoclonal antibodies |
04/02/1986 | EP0176493A1 Vaccinal polypeptides |
04/02/1986 | EP0176429A1 Compositions and process for protecting T lymphocytes against the etiological agent of lymphadenopathy and an acquired immunodepression syndrom |
04/02/1986 | EP0176365A2 Human monoclonal antibody and its preparation |
04/02/1986 | EP0176252A2 Assay method employing fluorescent cell incorporative dye |
04/02/1986 | EP0176170A1 Herpes simplex virus as a vector |
04/02/1986 | EP0175973A1 Support material for the use in immunoassays |
04/02/1986 | EP0175841A2 Method for the production of pertussis component vaccine and combined vaccine of pertussis antigen; diphtheria toxoid and tetanus toxoid |
04/01/1986 | US4579827 Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies |
03/27/1986 | WO1986001902A1 Specific binding materials, their preparation and use |
03/27/1986 | WO1986001834A1 Retroviral polypeptides associated with human cellular transformation |
03/27/1986 | WO1986001829A1 A vaccine utilizing an avirulent strain of a microbial pathogen |
03/27/1986 | WO1986001828A1 Cyclic double-stranded dna, process for its preparation, microorganism containing said cyclic double-stranded dna, and process for preparing protein containing antigen determinant site of poliovirus capside protein vp1 using the same |
03/27/1986 | WO1986001827A1 Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav) |
03/27/1986 | WO1986001826A1 Hepatitis a virus purified and triply cloned |
03/27/1986 | WO1986001808A1 Monoclonal antibodies and their use |
03/27/1986 | WO1986001807A1 Monoclonal antibodies and their use |
03/27/1986 | WO1986001806A1 Monoclonal antibodies and their use |
03/27/1986 | WO1986001805A1 Monoclonal antibodies and their use |
03/27/1986 | WO1986001804A1 Monoclonal antibodies and their use |
03/27/1986 | WO1986001802A1 Antigens of plasmodium falciparum |
03/27/1986 | WO1986001721A1 Cross-reactive and protective epitopes of circumsporozoite proteins |
03/27/1986 | WO1986001718A1 METHOD FOR OBTAINING THE COMPLEX FVIII/vWF OF THERAPEUTIC USE AND PRODUCTS RESULTING THEREFROM |
03/26/1986 | EP0175613A2 Immunogenic hav peptides |
03/26/1986 | EP0175586A2 Fluorescence polarization immunoassay for heavy antigens. |
03/26/1986 | EP0175290A2 Glycopeptides, method for their preparation and their use |
03/26/1986 | EP0175283A1 Recombinant dna and use thereof |
03/26/1986 | EP0175261A2 Hybrid particle immunogens |
03/25/1986 | US4578458 Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa |
03/25/1986 | US4578399 Use of the diterpene derivative forskolin for immunostimulation |
03/25/1986 | US4578270 Process for the preparation of lyophilized, adsorbed polyvalent vaccines |
03/25/1986 | US4578269 Immunogenic protein or peptide complex, method or producing said complex and the use thereof as an immune stimulant and as a vaccine |
03/25/1986 | US4578219 Contraceptive vaccine |
03/25/1986 | US4578217 Synthetic antigenic peptide derived from hepatitis B surface antigen |
03/19/1986 | EP0174874A2 Hybrid cell line producing monoclonal antibody cytolytic to trichomonas vaginalis |
03/19/1986 | EP0174853A2 Radiolabeled antibody fragments |
03/19/1986 | EP0174805A1 Immunodiagnostic methods |
03/19/1986 | EP0174759A1 Multispecific immunogenic proteins |
03/19/1986 | EP0174744A2 Fluorescent energy transfer with phycobiliproteins |
03/19/1986 | EP0174669A2 Process for the production of a hybrid DNA containing the complementary hepatitis A virus genome, this hybrid DNA and plasmid vector containing it, virus-specific proteins expressed by this hybrid DNA, vaccines containing and produced from these proteins |
03/19/1986 | EP0174528A1 Method for the determination of a substance capable of immunological binding |
03/19/1986 | EP0174444A2 Hepatitis surface antigen particle vaccine |
03/18/1986 | CA1201988A1 Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes |
03/13/1986 | WO1986001539A1 Method of producing monoclonal anti-idiotypic antibodies |
03/13/1986 | WO1986001533A1 Production of chimeric antibodies |
03/13/1986 | WO1986001517A1 Herpes virus specific immunological materials and methods |
03/13/1986 | WO1986001411A1 Anti-urokinase monoclonal antibody; its production and use |
03/13/1986 | WO1986001410A1 Antibody-metal ion complexes |
03/13/1986 | WO1986001409A1 Acid-cleavable compound |
03/13/1986 | WO1986001407A1 Monoclonal antibodies against metal chelates |
03/12/1986 | EP0174247A2 Strip for immunological analysis and method for its preparation |
03/12/1986 | EP0174228A1 Process for diagnosing human Papilloma virus infections, monoclonal antibodies specific for a type of human Papilloma virus, and hybridomalines secreting them |
03/12/1986 | EP0174204A2 Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof |
03/12/1986 | EP0174106A2 Detection of cell membrane protein |
03/12/1986 | EP0173999A2 Process for preparing a solution of milk and/or colostrum immunoglobins |
03/12/1986 | EP0173997A1 Feline leukemia virus protein vaccines and their preparation |
03/12/1986 | EP0173973A2 Method for the determination of thyroid-stimulating hormone |
03/12/1986 | EP0173951A2 Tumour therapeutic agent and process for its preparation |
03/12/1986 | EP0173889A2 Immunoamplifiers and processes for the extraction thereof |
03/12/1986 | EP0173712A1 Immunization by immunogenic implant |
03/11/1986 | US4575495 Vaccine |
03/11/1986 | US4575486 Process for differentiating the origin of particles in urine |
03/11/1986 | US4575485 Ultrasonic enhanced immuno-reactions |
03/11/1986 | US4575459 Immunotherapy |
03/11/1986 | CA1201667A1 Diagnostic reagent and method |
03/05/1986 | EP0173663A2 The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases |
03/05/1986 | EP0173629A1 Antibody-metal ion complexes |
03/05/1986 | EP0173500A1 Methods of concentrating ligands and active membranes used therefor |
03/05/1986 | EP0173494A2 Chimeric receptors by DNA splicing and expression |
03/05/1986 | EP0173384A2 Polypeptide relating to alpha-hANP |
03/05/1986 | EP0173341A1 Method for the determination of hormones |
03/05/1986 | EP0173268A2 A method for the preparation of a herpes simplex virus subunit vaccine |
03/05/1986 | EP0173254A1 DNA sequences of the EBV genome, recombinant DNA molecules, processes for producing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens |
03/05/1986 | EP0173242A2 Process for the production of a pasteurized isoagglutinin-free Faktor VIII preparation from a cryoprecipitate. |
03/05/1986 | EP0173241A2 Vaccines for the treatment of urinary tract infections |
03/05/1986 | EP0173228A2 Polysaccharide rin substance, production of the same and use of the same |
03/05/1986 | EP0173055A2 Binding assay with amplified read-out and gas-phase detection |
03/04/1986 | US4574058 Antigen derivatives and processes for their preparation |
03/04/1986 | CA1201396A1 Process for the preparation of permanent animal and human cell lines and their use |
02/27/1986 | WO1986001228A1 Immunogenic conjugates of e. coli lt-b enterotoxin subunit and capsular polymers |
02/27/1986 | WO1986001222A1 New hybride cells secreting anti-idiotypic antibodies, new monoclonal antibodies secreted by said hybride cells, preparation and application thereof |
02/27/1986 | WO1986001212A1 Minactivin |
02/27/1986 | WO1986001211A1 Immunotherapeutic polypeptide agents |
02/27/1986 | WO1986001210A1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
02/26/1986 | EP0172559A2 Polysaccharide RON substance, production of the same and use of the same |
02/26/1986 | EP0172471A2 Herpes virus specific immunological materials and methods |
02/26/1986 | EP0172212A1 Biological preparations and their use |
02/25/1986 | CA1201076A1 Vaccines for prevention of gastroenteric disease |
02/19/1986 | EP0172107A1 Immunogenic conjugates of E. coli LT-B enterotoxin subunit and capsular polymers |
02/19/1986 | EP0172045A1 Antitumour glycoproteins modified at their carbohydrate moieties, and process for obtaining them |
02/19/1986 | EP0171946A1 Specific binding method and composition |
02/19/1986 | EP0171908A2 Hepatitis B virus surface antigen and production thereof |
02/19/1986 | EP0171771A2 A method for purification of rabies virus |
02/19/1986 | EP0171765A2 A method for purification of japanese encephalitis virus |
02/19/1986 | EP0171506A1 A method for the heat treatment of plasma or plasma fractions and compositions obtained thereby |
02/19/1986 | EP0171496A2 Process for the production of a chimera monoclonal antibody |
02/19/1986 | EP0171455A1 Synthetic peptide, immune globulin and process for immunizing a mammal |
02/18/1986 | US4571386 Feline infectious peritonitis vaccine |
02/18/1986 | US4571385 Human-animal rotovirus combination |
02/18/1986 | US4571336 Immune stimulation |